VEGFA and coronary artery disorder: Li found that Shexiang Xintongning could promote angiogenesis by activating VEGF/VEGFR2 and ERK1/2 pathways to protect HUVECs from oxidative stress, reduce infarct size, and prevent AS plaque rupture-induced worsening CHD (40).